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Abstract The cloning of a cDNA encoding a G protein-coupled
receptor homologous to the endothelin type B receptor, but
unable to bind endothelin, was recently reported and termed
ETBR-LP. We report here the isolation of a human cDNA
encoding a receptor that is highly related to ETBR-LP and which
was therefore termed ETBR-LP-2. Comparison of the two amino
acid sequences revealed 68% overall homology and 48% identity.
As is the case for ETBR-LP, the new receptor is strongly
expressed in the human central nervous system (e.g. in cerebellar
Bergmann glia, cerebral cortex, internal capsule fibers).
Membranes of HEK-293 cells stably expressing ETBR-LP-2
did not bind endothelin-1, endothelin-2, endothelin-3, bombesin,
cholecystokinin-8 or gastrin-releasing peptide.
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1. Introduction
Endothelin is the most potent vasoconstricting substance
known to date [1]. The endothelin family includes three iso-
peptides (ET-1, ET-2 and ET-3) of 21 amino acid residues [2],
which exert their pleiotropic e¡ects through at least two re-
lated G protein-coupled receptors, termed ETA and ETB [3,4].
ETA binds preferentially ET-1 and ET-2, is located on smooth
muscle cells and is thought to be mainly responsible for the
endothelin-induced vasoconstriction. ETB on the other hand
binds all three isopeptides with comparable a⁄nities. It is
present on endothelial cells, and induces a dilatation of
smooth muscle cells through the release of prostacyclin, nitric
oxide or adrenomedullin by endothelial cells. The existence of
additional types of endothelin receptors has been suspected
for a long time. Thus, an ETC receptor with a higher a⁄nity
for ET-3 was pharmacologically distinguished [5,6]. A cDNA
encoding such a receptor was indeed cloned from Xenopus
laevis melanophore cells [7], but so far attempts to identify
its mammalian counterpart have not been successful. In addi-
tion, vasoconstriction induced by ETB agonists was believed
to be due to an additional endothelin receptor, which was
referred to as ETB2 [8]. We and others have recently shown
that this receptor was the previously known ETB receptor
[9,10], which thus can induce both constriction and relaxation
of smooth muscle cells. The only additional endothelin recep-
tors that could be identi¢ed so far correspond to splice var-
iants of the ETB receptor [11,12].
Recently, Zeng et al. reported the existence of a new G
protein-coupled receptor that was signi¢cantly homologous
to the endothelin ETB receptor and predominantly expressed
in brain [13]. However, this receptor could not bind endothe-
lins or other peptides such as bombesin and neuropeptide Y
when expressed in cells. In the search for receptors homolo-
gous to the endothelin receptors, we have also detected and
identi¢ed the same human receptor, which Zeng et al. named
ETBR-LP (ETB receptor-like protein). In addition, we isolated
a cDNA encoding a second human receptor, highly related to
ETBR-LP. We report here the identi¢cation and characteriza-
tion of this novel receptor, which has been termed ETBR-LP-
2.
2. Materials and methods
2.1. cDNA cloning
A cDNA fragment corresponding to a human expressed sequence
tag (EST; GenBank accession number HS771168) displaying a high
similarity to the ETB endothelin receptor sequence was ampli¢ed by
PCR from random-primed brain cDNA and used as a probe to screen
a human caudate nucleus cDNA library (Clontech). Library screening
was carried out as previously described [14] on approximately one
million phages. Twenty-¢ve strong and three faint signals were ob-
tained. The strong hybridization signals were shown by PCR to cor-
respond to a cDNA including the EST fragment. Analysis of a clone
weakly hybridizing to the probe revealed a di¡erent but highly related
sequence. The insert of this clone was then used to screen the same
caudate nucleus library. Twenty clones were obtained, the longest of
which was sequenced to completion.
2.2. Northern blot analysis
Total RNA (10 Wg) from HEK-293 cells was fractionated on a 1.2%
(w/v) agarose gel containing 20 mM morpholinopropane sulfonic acid,
5 mM sodium acetate, 1 mM EDTA and 1.8% (v/v) formaldehyde and
transferred overnight to Nylon N (Amersham) in 1UTAE (40 mM
Tris-acetate, 1 mM EDTA, pH 8.0) using a Transphor electrophoresis
unit (Hoefer Scienti¢c Instruments). Two blots, each displaying poly-
(A) RNA from eight human tissues, were purchased from Clontech.
The three membranes were hybridized with a 32P-random-primed
probe synthesized using the 1638 bp ETBR-LP-2 cDNA. Hybridiza-
tion (at 65‡C for 12 h in ExpressHyb solution (Clontech) containing
denatured herring sperm DNA (100 Wg/ml) and 106 cpm/ml of the
labelled probe) was followed by three steps of washing at 65‡C for 15
min each in 2USSC, 0.1% (w/v) SDS, in 1USSC, 0.1% (w/v) SDS,
and in 0.1USSC, 0.1% (w/v) SDS. The blots were then exposed to an
autoradiographic ¢lm for 12 h.
2.3. In situ hybridization histochemistry
An oligodeoxyribonucleotide probe complementary to the human
ETBR-LP-2 cDNA (corresponding to nucleotides 1444^1385) was la-
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belled at the 3P end with terminal deoxynucleotidyl transferase (Life
Technologies) and [35S]dATP then puri¢ed. Cryostat sections of hu-
man cerebellum, caudate putamen and temporal cortex were mounted
on Superfrost Plus slides and then ¢xed in phosphate-bu¡ered saline
(PBS, pH 7.4) containing 4% paraformaldehyde for 20 min followed
by three 5 min washes in PBS. Sections were hybridized in 50 Wl of
4USSC, 20% dextran sulfate, 50% deionized formamide, 0.1 M di-
thiothreitol, 0.5UDenhardt’s solution, containing denatured herring
sperm DNA (0.25 mg/ml) and 3U105 dpm of the 35S-labelled probe.
Sections were covered with Fuji¢lm coverslips and incubated in a
moist chamber at 43‡C overnight. After removal of the coverslips,
the sections were washed twice in 1USSC, 10 mM dithiothreitol for
15 min at 55‡C, then in 0.5USSC, 10 mM dithiothreitol once for 15
min at room temperature. After a dip in double distilled water, sec-
tions were dehydrated in ethanol and exposed to Hyper¢lm L-max
(Amersham Corp.) or Ilford K5 nuclear research emulsion.
2.4. Expression of ETBR-LP-2 in HEK-293 cells
A BamHI/SapI cDNA fragment containing a Kozak leader se-
quence (5P-GCCACC-3P) followed by the ¢rst 481 bp of the ETBR-
LP-2 coding sequence was synthesized by PCR, and ligated onto a
1112 bp SapI/EcoRI fragment (excised from a phage obtained by the
human caudate nucleus library screening) into the expression vector
pCEP4 (Invitrogen), resulting in the plasmid pETBR-LP-2. A human
embryonic kidney cell line (HEK-293) was cultured in MEMK me-
dium supplemented with 10% heat-inactivated fetal calf serum. HEK-
293 cells were transfected with the pETBR-LP-2 plasmid using lip-
ofectamine (Life Technologies) and were then selected using 100 U/
ml hygromycin. Resistant colonies were screened by Northern blot-
ting.
2.5. Radioligand binding assays
Competition binding assays with membranes of stably transfected
or control HEK-293 cells were performed using endothelin-1, endo-
thelin-2, endothelin-3, bombesin, cholecystokinin-8 and gastrin releas-
ing peptide as 125I-labelled ligands. Microsomal membranes were pre-
pared as described earlier [15], adding phenylmethylsulfonyl £uoride
(17.4 mg/l) and phenanthroline (19.8 mg/l) to prevent proteolytic deg-
radation. The assay mixture contained 250 Wl of 50 mM Tris bu¡er
(pH 7.4, 25 mM MnCl2, 1 mM EDTA, 0.5% (w/v) BSA), 0.1^35 Wg
protein and 30^100 pM 125I-labelled ligand (30 000^100 000 cpm).
After incubation for 2 h at 22‡C, bound and free ligand were sepa-
rated by ¢ltration. Each assay was performed three times in tripli-
cates. Non-speci¢c binding was assessed in the presence of 100^1000
nM of the corresponding unlabelled peptides.
3. Results and discussion
Searching for additional subtypes of endothelin receptors,
we noticed the presence of an EST in the GenBank database
that displayed a high homology with the ETB receptor se-
quence. The information given by this EST was used to isolate
a cDNA with an open reading frame of 1839 nucleotides from
a human caudate nucleus cDNA library. The encoded 613
amino acid protein displayed the structure of a seven trans-
membrane domain receptor and shared modest but signi¢cant
homology with the ETB receptor (37% similarity, 27% iden-
tity). Cloning of the same receptor cDNA was recently re-
ported by another group [13] who named the receptor
ETBR-LP (human ETB receptor-like protein). A few di¡er-
ences, possibly due to polymorphisms (or to inaccurate se-
quencing), could be detected when comparing our sequence
to that of Zeng et al. [13]. One of these di¡erences represents a
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Fig. 1. a: cDNA sequence and deduced amino acid sequence of
ETBR-LP-2. The potential seven transmembrane domains are under-
lined. ‡ and * indicate putative sites for N-linked glycosylation and
protein kinase C phosphorylation, respectively. b: Alignment of the
amino acid sequences of ETBR-LP (bottom sequence) and ETBR-
LP-2 (top sequence).
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silent mutation (C instead of T2825 or C/T2825), while the rest
of them change the amino acid content of ETBR-LP: G/A2056
(G/D93), G/A2094 (A/T106), G/T2131 (G/V118), G/T2257 (G/V160),
G/T2324 (W/C182), G/T2471 (E/D231), C/T2689 (A/V304), C/G2763
(L/V329), T/G3286 (F/L503), T/G3287 (C/G504) and A/G3570 (T/
A598). In agreement with Zeng et al. [13], we found high levels
of the mRNA of ETBR-LP mRNA in the brain, especially in
the corpus callosum, and did not detect any binding of ET-1
or ET-3 to cells stably expressing the receptor.
In addition to strong hybridization signals corresponding to
ETBR-LP cDNA clones, a few very faint signals could be
detected by screening the human caudate nucleus library. Pu-
ri¢cation and analysis of one of these weakly hybridizing
clones revealed a sequence di¡erent but highly related to the
sequence of ETBR-LP. This incomplete cDNA was used as a
probe to rescreen the cDNA library. The longest of the 20
clones detected (as assessed by PCR) was puri¢ed and thor-
oughly sequenced. It contained a sequence of 1638 bp with an
open reading frame of 1443 nucleotides, encoding a putative
protein of 481 amino acid residues (Fig. 1A). This protein
displayed the common features of G protein-coupled recep-
tors, including the presence of seven hydrophobic putatively
transmembrane stretches. Like all the members of this recep-
tor family, it also displays two cysteines in the ¢rst and second
extracellular loops, which are believed to form a disul¢de
bridge, and several other conserved residues, such as an as-
partic acid in the second transmembrane domain and the ‘D/
E-R-Y/F’ motif in the second cytoplasmic loop. Due to its
high homology (68% similarity and 48% identity, Fig. 1B)
with ETBR-LP, this new receptor was termed ETBR-LP-2.
Like ETBR-LP and the endothelin receptors, ETBR-LP-2
has a putative signal peptide. In addition, it displays a poten-
tial site for protein kinase C phosphorylation (third cytoplas-
mic loop) and one potential site for N-linked glycosylation
(N-terminal extracellular domain). An interesting feature of
ETBR-LP-2, which is also shared by ETBR-LP and by the
two endothelin receptors, is the presence of a cluster of cys-
teines (residues 430^436 in Fig. 1) in its C-terminal extremity.
Several G protein-coupled receptors have been shown exper-
imentally to be palmitoylated on cysteine residues in their
cytoplasmic tails ; in particular, palmitoylation of ETA and
ETB receptors is believed to modulate their coupling with G
proteins [16,17].
The distribution of ETBR-LP-2 mRNA in human tissues
was assessed by Northern blotting, using a 1638 bp probe
encompassing the whole coding sequence of ETBR-LP-2
(Fig. 2). Hybridization of the probe to the blots failed to
detect any signal in peripheral tissues (heart, placenta, lung,
liver, skeletal muscle, kidney, pancreas). In contrast, one
strong signal of 2.8 kbp and two weaker signals of 4.5 kbp
and 7.5 kbp could be observed in brain. The presence of three
FEBS 19937 11-3-98
Fig. 3. Regional distribution of ETBR-LP-2 transcripts (a) and cellular sites of synthesis (b) in human cerebellum, revealed by in situ hybridiza-
tion histochemistry. Arrowheads identify the Bergmann glia of the Purkinje cell layer. Note the lack of hybridization signal in Purkinje neurons
(P).
Fig. 2. Tissue expression of ETBR-LP-2 mRNA analyzed by North-
ern blotting. Each sample contains 2 Wg of poly(A) RNA, except
for lanes 17 and 18 (10 Wg of total RNA). Markers of known mo-
lecular weight are indicated (in kbp). Lane 1, heart; 2, brain; 3, pla-
centa; 4, lung; 5, liver; 6, skeletal muscle; 7, kidney; 8, pancreas;
9, cerebellum; 10, cortex; 11, medulla; 12, spinal cord; 13, occipital
lobe; 14, frontal lobe; 15, temporal lobe; 16, putamen; 17, HEK-
293 cells stably transfected with human ETBR-LP-2; 18, non-trans-
fected HEK-293 cells.
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di¡erent signals could correspond to the existence of distinct
polyadenylation sites in the ETBR-LP-2 gene. The expression
of ETBR-LP-2 was further analyzed in the central nervous
system. A similar pattern of three signals, with a strong signal
of 2.8 kbp, was detected by Northern blot in cerebellum,
cortex, medulla, spinal cord and putamen, as well as in the
occipital, frontal and temporal lobes. In situ hybridization
histochemistry was performed with an 35S-labelled speci¢c
oligonucleotide to determine the sites of synthesis of ETBR-
LP-2 in human cerebellum, caudate putamen and temporal
cortex. Extremely high levels of transcripts were detected in
the cerebellar Bergmann glia of the Purkinje cell layer, where-
as adjacent Purkinje cells and granule cells were not labelled
(Fig. 3). This is in contrast to the reported expression of the
related receptor ETBR-LP in cerebellar Purkinje neurons [13].
A moderate to strong hybridization signal was also detected in
the internal capsule ¢bers of the caudate putamen and in
temporal cortex (not shown).
The ETBR-LP-2 receptor was stably expressed in HEK-293
cells, as was con¢rmed by Northern blot analysis (Fig. 2). In
competition binding assays performed on cell membranes, no
signi¢cant di¡erence was observed between ETBR-LP-2 trans-
fected and non-transfected HEK-293 cells for any of the
tested ligands, i.e. ET-1, ET-2, ET-3, bombesin, cholecystoki-
nin-8 and gastrin-releasing peptide. A weak binding of ET-1
could be attributed to a small number (18 fmol/mg protein) of
ETA receptors present in non-transfected HEK 293 cells. Sim-
ilar results were obtained in our hands with HEK-293 cells
expressing the related ETBR-LP receptor, in agreement with
Zeng et al. [13] who could not detect any binding with endo-
thelin-1, endothelin-3 and bombesin.
In view of the strong homology that they share, ETBR-LP
and ETBR-LP-2 receptors most likely bind the same ligand, or
at least some closely related ligands. Their high levels of ex-
pression in human brain (preferentially, but perhaps non-ex-
clusively, in neurons and glia, respectively) indicate their phys-
iological importance. We speculate that they are part of a
novel peptidergic system that remains to be identi¢ed.
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